Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder
Public ClinicalTrials.gov record NCT00034580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Olanzapine Versus Active Comparator in the Treatment of Bipolar I Disorder, Manic or Mixed
Study identification
- NCT ID
- NCT00034580
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 326 participants
Conditions and interventions
Conditions
Interventions
- olanzapine Drug
- risperidone Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2001
- Primary completion
- Not listed
- Completion
- Jul 31, 2002
- Last update posted
- Jul 18, 2006
2001 – 2002
United States locations
- U.S. sites
- 21
- U.S. states
- 16
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Berkley | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Orange | California | — | — |
| Not listed | San Marcos | California | — | — |
| Not listed | Torrance | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Middleton | Connecticut | — | — |
| Not listed | Washington D.C. | District of Columbia | — | — |
| Not listed | Winter Park | Florida | — | — |
| Not listed | Boise | Idaho | — | — |
| Not listed | Hoffman Estates | Illinois | — | — |
| Not listed | Natick | Massachusetts | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Clementon | New Jersey | — | — |
| Not listed | Olean | New York | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Madison | Tennessee | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Roanoke | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00034580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2006 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00034580 live on ClinicalTrials.gov.